QT Imaging Holdings Inc(QTI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:02 PM ET (Korea 11/4 06:02)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.57 | Insider Own | 21.76% | Shs Outstand | 13.8M | Perf Week | -5.26% |
| Market Cap | 0.03B | Forward P/E | 864 | EPS next Y | 100.24% | Insider Trans | - | Shs Float | 11.4M | Perf Month | -17.24% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.09 | Inst Own | 22.31% | Short Float | 1.66% | Perf Quarter | -21.17% |
| Income | -0.02B | P/S | 1.2 | EPS this Y | 48.92% | Inst Trans | 14.43% | Short Ratio | 5.98 | Perf Half Y | -68.19% |
| Sales | 0.03B | P/B | 13.24 | EPS next 5Y | - | ROA | -96.64% | Short Interest | 0.19M | Perf YTD | -64.59% |
| Book/sh | 0.16 | P/C | 2.88 | EPS past 3/5Y | -61.26% -105.48% | ROE | -2125.24% | 52W High | -71.58% ($7.60) | Perf Year | -68.6% |
| Cash/sh | 0.75 | P/FCF | - | Sales past 3/5Y | - | ROIC | -116.44% | 52W Low | 0.93% ($2.14) | Perf 3Y | -93.36% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 25.98% | Gross Margin | 40.39% | Volatility(W/M) | 5.7% 7.52% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.38 | Sales Y/Y TTM | 219.99% | Oper. Margin | -24.84% | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.06 | EPS Q/Q | -76.29% | Profit Margin | -77.26% | RSI (14) | 32.41 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.1 | Sales Q/Q | 103.17% | SMA20 | -8.63% ($2.36) | Beta | 0.04 | Target Price | $10.05 |
| Payout | - | Debt/Eq | 6.99 | Earnings | 2026/11/10 | SMA50 | -15.72% ($2.56) | Rel Volume | 0.64 | Prev Close | $2.15 |
| Employees | 32 | LT Debt/Eq | 6.8 | EPS/Sales Surpr. | -240.91% -2.17% | SMA200 | -51.39% ($4.44) | Avg Volume(3M) | 0.03M | Price | $2.16 |
| IPO | 2021/11/4 | Option/Short | No/Yes | Trades | 129 | Volume | 20,433 | Change | 0.47% |
🏥 A U.S. medical device company specializing in innovative 3D breast ultrasound imaging technology that eliminates radiation exposure and compression pain. Through its proprietary "Breast Acoustic CT™" system, it delivers precise early-diagnostic solutions for women with dense breasts, driving innovation in the breast cancer screening market.
Over the past 1 year, on the lower side
72% below its 1-year high.
Traded less than usual. That is 64% of its average volume.
Next earnings report: November 10
6 days to go.
QTI has weak earnings and a weak balance sheet
Of every $100 in sales, $24.84 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +48.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $120. Peers typically go for $145.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -93.4%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 22.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #104 of 140 in the industry
Based on market cap of $32M.
ELUT#101 Elutia Inc $36M PER - 
RPID#102 Rapid Micro Biosystems Inc $35M PER - 
NSYS#103 Nortech Systems Inc $32M PER 32.4 QTI#104 QT Imaging Holdings Inc $32M PER - 
NSPR#105 InspireMD Inc $31M PER - 
FAQ
What kind of company is QTI?
QTI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of QTI?
The market cap of QTI is approximately $32M, ranking 5,052 within its sector.
What is the 52-week high and low for QTI?
QTI has recorded a 52-week high of $7.60 and a low of $2.14.
